Market Overview:
The global cardiac valve market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of heart diseases, technological advancements in cardiac valve treatment, and rising demand for minimally invasive procedures. The global cardiac valve market is segmented by type into trans-catheter heart valves, tissue heart valves, mechanical heart valves, and others. The trans-catheter heart valves segment is expected to grow at the highest CAGR during the forecast period owing to the increasing use of these devices for treating valvular diseases. By application, the cardiac research institute segment is expected to grow at a higher CAGR than hospital & clinics during the forecast period owing to increased funding for cardiovascular research activities across different regions. Geographically, North America dominates the global cardiac valve market followed by Europe and Asia Pacific.
Product Definition:
A cardiac valve is a flap of tissue that helps regulate blood flow through the heart by opening and closing as the heart muscle contracts and relaxes. There are four valves in the human heart: two atrioventricular valves (the mitral valve and tricuspid valve) between the upper chambers (the atria) and two semilunar valves (the pulmonary valve and aortic valve) between the lower chambers (the ventricles).
Trans-Catheter Heart Valve:
Trans-catheter heart valve is a medical device used to treat and prevent heart failure, which occurs due to the enlargement of left or right atrial appendage (a small blood vessel that connects the left and right atria) or both atria. The product also helps in reducing the risk of stroke and cardiovascular death in patients suffering from high blood pressure, coronary artery disease, rheumatic heart disease, congenital structural defects or other valvular diseases.
Tissue Heart Valve:
A tissue heart valve is a small, flexible device that allows blood to pass through the damaged heart chamber. It is implanted in the patient’s body and can be used for up to 10 years. The valve helps in reducing the pressure inside the chambers and thus reduces stress on cardiac muscles.
Application Insights:
Based on application, the global cardiac valve market is segmented into cardiac research institute, hospital & clinics, and others. The hospital & clinics segment dominated the market in 2017 due to increasing prevalence of cardiovascular diseases and rising number of surgeries. According to a study published by WHO in 2018, it was estimated that around 1 billion people suffer from some form of heart disease globally which includes about 80% men and 20% women population above 40 years old worldwide.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to various factors such as favorable reimbursement policies, increasing awareness about advanced technologies and presence of major market players in this region. Moreover, growing geriatric population and high incidence of CVDs are expected to drive the growth during the forecast period. Europe is also anticipated to witness significant growth over the forecast period due to rapid technological advancements and presence of well-established healthcare facilities in this region.
Growth Factors:
- Increasing incidence of cardiac valve diseases
- Growing geriatric population
- Rising demand for minimally invasive cardiac valve procedures
- Technological advancements in cardiac valve treatment therapies
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Cardiac Valve Market Research Report
By Type
Trans-Catheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve, Others
By Application
Cardiac Research Institute, Hospital & Clinics, Others
By Companies
Boston Scientific, Abbott, LivaNova, Symetis, Jenavalve Technology, CryoLife, TTK HealthCare, Colibri Heart Valve, Lepu Medical Technology, Braile Biomédica, Boston Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
194
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Cardiac Valve Market Report Segments:
The global Cardiac Valve market is segmented on the basis of:
Types
Trans-Catheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiac Research Institute, Hospital & Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific
- Abbott
- LivaNova
- Symetis
- Jenavalve Technology
- CryoLife
- TTK HealthCare
- Colibri Heart Valve
- Lepu Medical Technology
- Braile Biomédica
- Boston Scientific
Highlights of The Cardiac Valve Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Trans-Catheter Heart Valve
- Tissue Heart Valve
- Mechanical Heart Valve
- Others
- By Application:
- Cardiac Research Institute
- Hospital & Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cardiac Valve Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A cardiac valve is a device that helps control the flow of blood through the heart. The valves are made up of two parts: an upper valve and a lower valve. The upper valve opens to allow blood in, and the lower valve closes to prevent backflow.
Some of the major companies in the cardiac valve market are Boston Scientific, Abbott, LivaNova, Symetis, Jenavalve Technology, CryoLife, TTK HealthCare, Colibri Heart Valve, Lepu Medical Technology, Braile Biom©dica, Boston Scientific.
The cardiac valve market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cardiac Valve Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cardiac Valve Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cardiac Valve Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cardiac Valve Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cardiac Valve Market Size & Forecast, 2020-2028
4.5.1 Cardiac Valve Market Size and Y-o-Y Growth
4.5.2 Cardiac Valve Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Trans-Catheter Heart Valve
5.2.2 Tissue Heart Valve
5.2.3 Mechanical Heart Valve
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cardiac Research Institute
6.2.2 Hospital & Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cardiac Valve Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cardiac Valve Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Trans-Catheter Heart Valve
9.6.2 Tissue Heart Valve
9.6.3 Mechanical Heart Valve
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cardiac Research Institute
9.10.2 Hospital & Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Trans-Catheter Heart Valve
10.6.2 Tissue Heart Valve
10.6.3 Mechanical Heart Valve
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cardiac Research Institute
10.10.2 Hospital & Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Trans-Catheter Heart Valve
11.6.2 Tissue Heart Valve
11.6.3 Mechanical Heart Valve
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cardiac Research Institute
11.10.2 Hospital & Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Trans-Catheter Heart Valve
12.6.2 Tissue Heart Valve
12.6.3 Mechanical Heart Valve
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cardiac Research Institute
12.10.2 Hospital & Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Trans-Catheter Heart Valve
13.6.2 Tissue Heart Valve
13.6.3 Mechanical Heart Valve
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cardiac Research Institute
13.10.2 Hospital & Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cardiac Valve Market: Competitive Dashboard
14.2 Global Cardiac Valve Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific
14.3.2 Abbott
14.3.3 LivaNova
14.3.4 Symetis
14.3.5 Jenavalve Technology
14.3.6 CryoLife
14.3.7 TTK HealthCare
14.3.8 Colibri Heart Valve
14.3.9 Lepu Medical Technology
14.3.10 Braile Biomédica
14.3.11 Boston Scientific
